The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer.

The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer.

Item
http://www.wikidata.org/entity/Q35689822
Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trialsAssessing the cardiovascular risk of hormonal therapy in patients with prostate cancer.Cardiovascular toxicities of systemic treatments of prostate cancer.Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives.Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors.Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation.
P2860

The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer.

Item
http://www.wikidata.org/entity/Q35689822
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The incidence and relative ris ...... ion-resistant prostate cancer.
@ast
The incidence and relative ris ...... ion-resistant prostate cancer.
@en
type
label
The incidence and relative ris ...... ion-resistant prostate cancer.
@ast
The incidence and relative ris ...... ion-resistant prostate cancer.
@en
prefLabel
The incidence and relative ris ...... ion-resistant prostate cancer.
@ast
The incidence and relative ris ...... ion-resistant prostate cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The incidence and relative ris ...... tion-resistant prostate cancer
@en
P2093
P304
P31
P356
10.1016/J.EJCA.2015.06.106
P433
P478
P50
P577
P5875
P698